DK2151241T3 - Stabilt fast præparat, omfattende 4,5-epoxymorphinanderivat - Google Patents

Stabilt fast præparat, omfattende 4,5-epoxymorphinanderivat

Info

Publication number
DK2151241T3
DK2151241T3 DK08752145.6T DK08752145T DK2151241T3 DK 2151241 T3 DK2151241 T3 DK 2151241T3 DK 08752145 T DK08752145 T DK 08752145T DK 2151241 T3 DK2151241 T3 DK 2151241T3
Authority
DK
Denmark
Prior art keywords
solid preparation
stable solid
derivative
epoxymorphinander
effective ingredient
Prior art date
Application number
DK08752145.6T
Other languages
English (en)
Inventor
Suguru Takaki
Kotoe Ohta
Yasuhide Horiuchi
Masato Kobayashi
Junko Kawasaki
Eijiro Horisawa
Original Assignee
Toray Industries
Maruho Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries, Maruho Kk filed Critical Toray Industries
Application granted granted Critical
Publication of DK2151241T3 publication Critical patent/DK2151241T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Epoxy Compounds (AREA)
  • Epoxy Resins (AREA)
DK08752145.6T 2007-04-26 2008-04-25 Stabilt fast præparat, omfattende 4,5-epoxymorphinanderivat DK2151241T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007116721 2007-04-26
PCT/JP2008/058111 WO2008133330A1 (ja) 2007-04-26 2008-04-25 ４，５－エポキシモルヒナン誘導体を含有する安定な固形製剤

Publications (1)

Publication Number Publication Date
DK2151241T3 true DK2151241T3 (da) 2012-04-23

Family

ID=39925776

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08752145.6T DK2151241T3 (da) 2007-04-26 2008-04-25 Stabilt fast præparat, omfattende 4,5-epoxymorphinanderivat

Country Status (14)

Country Link
US (1) US8420662B2 (da)
EP (1) EP2151241B1 (da)
JP (2) JP5099127B2 (da)
KR (1) KR101491656B1 (da)
CN (1) CN101686976B (da)
AT (1) ATE550023T1 (da)
AU (1) AU2008244936B2 (da)
CA (1) CA2685131C (da)
DK (1) DK2151241T3 (da)
ES (1) ES2381056T3 (da)
MX (1) MX2009011554A (da)
PL (1) PL2151241T3 (da)
PT (1) PT2151241E (da)
WO (1) WO2008133330A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI455733B (zh) 2009-03-30 2014-10-11 Toray Industries 口腔內崩壞性被覆錠劑
EP2630150B1 (en) 2010-10-19 2017-04-12 Memorial Sloan-Kettering Cancer Center 6-amido derivatives of 4,5a-epoxymorphinans for treatment of pain
JP2013087170A (ja) * 2011-10-17 2013-05-13 Nippon Soda Co Ltd ヒドロキシプロピルセルロース微粒子
US10952968B2 (en) 2012-05-14 2021-03-23 Shionogi & Co., Ltd. Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives
GB201318394D0 (en) * 2013-10-17 2013-12-04 Univ Edinburgh Composition
US11046692B2 (en) 2015-04-30 2021-06-29 Memorial Sloan-Kettering Cancer Center Mitragynine analogs and uses thereof
CN105461727A (zh) * 2015-12-01 2016-04-06 吕涛 一种纳呋拉啡的精制方法
TWI740994B (zh) 2016-07-29 2021-10-01 日商東麗股份有限公司 經光穩定性提升之固體製劑
KR102631066B1 (ko) 2017-03-31 2024-01-30 도레이 카부시키가이샤 날푸라핀을 함유하는 정제화된 의약 조성물
WO2019171333A1 (en) 2018-03-08 2019-09-12 Victoria Link Ltd Treatment of demyelinating diseases
CN113614089A (zh) 2019-03-29 2021-11-05 人福医药美国公司 可用于治疗医学病症的新型吗啡喃
IL309232A (en) 2021-06-14 2024-02-01 Scorpion Therapeutics Inc History of urea which can be used to treat cancer
EP4212149A1 (en) * 2022-01-18 2023-07-19 Rijksuniversiteit Groningen Oral dosage forms of acid-labile salt and methods and uses related thereto

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8820327D0 (en) 1988-08-26 1988-09-28 May & Baker Ltd New compositions of matter
ATE172201T1 (de) 1992-01-23 1998-10-15 Toray Industries Morphinan-derivate und medizinische verwendung
DE69728585T2 (de) * 1996-11-25 2004-08-05 Toray Industries, Inc. Mittel gegen Juckreiz
WO1998035679A1 (de) 1997-02-14 1998-08-20 Gödecke Aktiengesellschaft Stabilisierung von naloxonhydrochlorid
TW580397B (en) * 1997-05-27 2004-03-21 Takeda Chemical Industries Ltd Solid preparation
JP4939680B2 (ja) 1997-05-27 2012-05-30 武田薬品工業株式会社 固形製剤
JP3617055B2 (ja) * 1997-07-11 2005-02-02 東レ株式会社 ４，５―エポキシモルヒナン誘導体を含有する安定な医薬品組成物
US6524568B2 (en) * 1998-06-22 2003-02-25 Cytomedix, Inc. Enriched platelet wound healant
EP1133984B1 (en) * 2000-03-17 2005-05-11 Shin-Etsu Chemical Co., Ltd. Solid preparation containing low-substituted hydroxypropyl cellulose and production process thereof
JP3698652B2 (ja) 2000-03-17 2005-09-21 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロース含有固形製剤及びその製造方法
JP4802436B2 (ja) 2000-04-12 2011-10-26 Ｍｓｄ株式会社 口腔内崩壊型組成物及び口腔内崩壊型製剤
JP3595765B2 (ja) * 2000-09-27 2004-12-02 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースを含む乾式直打用基剤
WO2002070013A1 (fr) 2001-03-06 2002-09-12 Kyowa Hakko Kogyo Co., Ltd. Utilisation d'une poudre sechee par atomisation contenant un alcool de sucre
WO2003077867A2 (en) 2002-03-14 2003-09-25 Euro-Celtique, S.A. Naltrexone hydrochloride compositions
US20050208127A1 (en) * 2002-06-10 2005-09-22 Kazuyoshi Ogasawara Rapidly disintegrating tablet and process for producing the same
CN104383542B (zh) 2003-04-08 2017-09-26 普罗热尼奇制药公司 包含甲基纳曲酮的药物配方

Also Published As

Publication number Publication date
AU2008244936B2 (en) 2013-02-21
CN101686976A (zh) 2010-03-31
EP2151241A1 (en) 2010-02-10
CN101686976B (zh) 2013-04-24
KR101491656B1 (ko) 2015-02-09
JP5578199B2 (ja) 2014-08-27
KR20100015582A (ko) 2010-02-12
US8420662B2 (en) 2013-04-16
EP2151241A4 (en) 2010-06-02
US20100120815A1 (en) 2010-05-13
CA2685131C (en) 2015-05-19
WO2008133330A1 (ja) 2008-11-06
ES2381056T3 (es) 2012-05-22
CA2685131A1 (en) 2008-11-06
JP2012180382A (ja) 2012-09-20
PL2151241T3 (pl) 2012-08-31
ATE550023T1 (de) 2012-04-15
AU2008244936A1 (en) 2008-11-06
PT2151241E (pt) 2012-05-07
JP5099127B2 (ja) 2012-12-12
MX2009011554A (es) 2010-01-25
EP2151241B1 (en) 2012-03-21
JPWO2008133330A1 (ja) 2010-07-29

Similar Documents

Publication Publication Date Title
DK2151241T3 (da) Stabilt fast præparat, omfattende 4,5-epoxymorphinanderivat
UA109421C2 (uk) Фармацевтична композиція, яка містить ліганди сигма-рецептора
EA201070698A1 (ru) Твердые формы 3-(6-(1-(2,2-дифторбензо[d][1,3]-диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
MA32604B1 (fr) Composes organiques
UY28797A1 (es) 5,6-dialquil-7-amino-triazolopirimidinas, procedimientos para su preparación y el uso de las mismas para combatir hongos nocivos, así como productos que las contienen.
BR112012018384A2 (pt) composição farmacêutica sólida com intensificadores e métodos de preparação da mesma.
NO20045072L (no) Tablett med hoyt medikamentinnhold
MA31433B1 (fr) Inhibiteurs de la p70 s6 kinase
AR072261A1 (es) Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos.
TNSN08505A1 (fr) Compositions pharmaceutiques stabilisees comprenant de la fesoterodine
MY151295A (en) Pyrimidyl indoline compound
EA200800817A1 (ru) Пестицидные производные бифениламидина
CO6280584A2 (es) Derivados heterociclicos fungicidas de (tetrazolil-benzilideneamido)-oximetil
ATE520406T1 (de) Kristalline form des ibandronat-natriums
UA105229C2 (uk) Фармацевтичний склад
EA201291410A1 (ru) Фармацевтические композиции, содержащие 4-амино-5-фтор-3-[6-(4-метилпиперазин-1-ил)-1h-бензимидазол-2-ил]-1h-хинолин-2-она лактат моногидрат
ECSP088689A (es) NOVEDOSAS 11ß-HIDROXIANDROSTA-4-EN-3-ONAS
EA201300715A1 (ru) Бульонный кубик
GT201400027A (es) Acuosa suspensión concentrada que comprende un ácido sal de dodecilguanidina
MA30554B1 (fr) Malates et formes polymorphes de l'acide ( 3s,5s)-7-[3-amino-5-methyl-piperidinyl ]-1-cyclopropyl-1,4-dihydro-8- methoxy-4-oxo-3-quinoleine-carboxylique
EA201000434A1 (ru) Сокристаллы пириметанила и дитианона
CO6351744A2 (es) Sales de n-[6-(cis-2,6-dimetil-morfolin-4-il)-piridini-3-il]-2-metil-4´-(trifluoro-metoxi)-[1,1´-bifenil]-3-carboxamida
TN2010000585A1 (en) Pharmaceutical compositions of rosuvastatin calcium
UY28798A1 (es) 5,6-dialquil-7-amino-triazolopirimidinas, procedimientos para su preparación y el uso de las mismas para combatir hongos nocivos, así como productos que las contienen
TR201906042T4 (tr) Stabilize edilmiş aktif bileşik.